StreetAlpha.app
Home › Stocks › NUTX

Nutex Health Inc. (NUTX)

Healthcare
$162.64
▲ +0.33%
LAST CLOSE · NOV 20

Nutex Health runs small hospitals and physician provider networks, serving patients across the United States. It last closed at $162.64 on Nov 20, up 0.33% on the day. The next earnings report for NUTX is expected around Thu, Mar 4, 2027, after the close. For the quarter ended Sep 2026, NUTX reported EPS of $5.71 on revenue of $217.6M, with revenue down 18.7% from a year ago. Over its last 8 reports the stock moved an average of 16.4% the session after earnings. Over the last 12 months NUTX insiders bought $148K of stock on the open market and sold $43K, according to SEC Form 4 filings.

AI Auto Pilots
Is NUTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold NUTX.

Key Stats

Last 12 months
Results
Revenue
$796.5M
−18.8% vs a year ago
Net income
$164.7M
+36.6% vs a year ago
EPS (diluted)
$23.11
+12.9% vs a year ago
Free cash flow
$248.1M
31.1% margin
Valuation
Market cap
$1.1B
6.9M shares
P/E
7.0
Price over 12 month EPS
Price to sales
1.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$249.9M
At Sep 30
Debt
$42.3M
At Sep 30
Shareholder equity
$435.6M
Buybacks
$55.7M
Last 12 months
Employees1,093 (Sep 30, 2026)
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $331.5M$331.5MFY2021FY2022: $219.3M$219.3MFY2022FY2023: $247.6M$247.6MFY2023FY2024: $479.9M$479.9MFY2024FY2025: $875.3M$875.3MFY2025

From NUTX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Mar 4
Estimated date · After the close
Reported EPS
$5.71
Quarter ended Sep 2026
Year ago EPS
$7.76
−26.4% on a GAAP basis
Revenue
$217.6M
−18.7% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $11.12Dec '24Mar 2025: $3.33Mar '25Jun 2025: -$2.95Jun '25Sep 2025: $7.76Sep '25Dec 2025: $1.61Dec '25Mar 2026: $6.52Mar '26Jun 2026: $9.38Jun '26Sep 2026: $5.71Sep '26Latest $5.71
Revenue by quarter
Dec 2024: $257.6MDec '24Mar 2025: $211.8MMar '25Jun 2025: $244.0MJun '25Sep 2025: $267.8MSep '25Dec 2025: $151.7MDec '25Mar 2026: $216.5MMar '26Jun 2026: $210.8MJun '26Sep 2026: $217.6MSep '26Latest $217.6M
How NUTX moved after its last 8 reports
Average move the session after a report ±16.4%
Nov 5, 2026After the close−6.8%
Aug 6, 2026After the close+6.7%
Apr 30, 2026After the close+17.1%
Mar 5, 2026After the close−14.3%
Nov 19, 2025After the close+26.9%
Oct 20, 2025Time not announced+17.1%
Aug 14, 2025After the close−16.4%
May 13, 2025After the close+26.1%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on NUTXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on NUTX
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on NUTX

Technical Analysis

NUTX · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold

The stock is 15% below its 20 day and 23% below its 50 day average. It is 6% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 37), near oversold. The nearest support is the Pivot at $161.16, and the nearest resistance the Pivot R1 at $167.27.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 7.9%/day
Key levels
$226.1652 week high+39.1%
$199.5950 day average+22.7%
$195.07Swing high (Aug 20)+19.9%
$188.17100 day average+15.7%
$187.0620 day average+15.0%
$167.27Pivot R1+2.8%
$162.64Last close
$161.16Pivot−0.9%
$156.52Pivot S1−3.8%
$152.76200 day average−6.1%
$142.91Swing low (Jun 22)−12.1%
$83.9952 week low−48.4%
Indicators
RSI (14)37.00Weak, oversold below 30Neutral
MACD-9.50Below its signal lineBearish
Stochastic10.3Near the bottom of its rangeOversold
ADX (14)23.6Weak trend
Williams %R-85.2Oversold below −80, overbought above −20Oversold
CCI (20)-134.1Oversold below −100, overbought above 100Oversold
Rate of change−9.9%Change over 10 sessionsBearish
ATR (14)$12.90Typical daily range, 7.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for NUTX

What happened before

See how NUTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow NUTX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How NUTX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2022.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for NUTXHow many large options trades hit NUTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

NUTX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲106 buying vs 66 selling
  • ▲Held by funds +8.0 pts
  • ▲Funds holding +29
  • ▼Superinvestors: 0 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding184155+18.7%
In funds' top 1032+50.0%
Held by funds50.9%42.8%+8.0 pts
New / increased44 / 6236 / 63+7.1%
Reduced / sold out51 / 1535 / 12+40.4%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See NUTX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

NUTX Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$148K5 buys · 5 insiders
Sold$43K1 sale · 1 insider
2026-03 bought $46K2026-09 sold $43KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Sep 18Scott J SaundersDirectorSale203$214.25$43K
Mar 20Frank E JaumotDirectorBuy150$93.56$14K
Mar 19Warren HosseinionPresidentBuy252$94.07$24K
Mar 17Kelvin SpearsDirectorBuy10$94.46$945
Mar 13Pamela W. MontgomeryChief Legal Officer-HealthcareBuy79$88.87$7K
Nov 25, 2025Jon Christian BatesCFOBuy750$136.71$103K
Every insider buy and sale for NUTX over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See NUTX insider trades →

From SEC Form 4 filings by NUTX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NUTX is in one of them and how their past NUTX trades turned out.

NUTX in the AI portfolios
Loading…

NUTX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NUTX in an article yet. Here's the latest on the wider market.

NUTX in the news

About Nutex Health

Nutex Health is a healthcare services company based in Houston, Texas. It runs a network of small hospitals that provide emergency care, inpatient stays, behavioral health, and onsite imaging and lab services. It also manages provider networks of independent physician groups that contract with health plans to care for patients. Its main payers are patients, private insurers, and federal government health programs.

Headquarters
Houston, TX